SOURCE: IBC Life Sciences

IBC Life Sciences

November 04, 2009 13:30 ET

IBC Life Sciences Announces Biopharmaceutical Development & Production Week March 1-5, 2010 in Carlsbad, California

WESTBOROUGH, MA--(Marketwire - November 4, 2009) - IBC Life Sciences is pleased to announce Biopharmaceutical Development & Production Week, which includes five conferences bringing in perspectives from multiple biopharmaceutical disciplines all under one roof.

The event, taking place March 1-5 at the La Costa Resort & Spa in Carlsbad, CA, provides biopharmaceutical professionals with the opportunity for an interactive and customized learning experience. The weeklong event features face-to-face networking with over 700 industry peers and over 119 presentations that include extensive case studies, interactive workshop sessions, industry panels, and strategic discussion groups.

The week begins with three separate conferences on March 1-2: Process & Product Validation, Technology Transfer for Biopharmaceuticals, and Outsourcing Manufacturing of Biopharmaceuticals. Then rounding out the week IBC will host its flagship Antibody Development & Production conference on March 3-5 which will be held alongside the Recombinant Protein for Complex Biologics Development & Production conference.

Keynote Presentations throughout the week include:

--  Life Sciences Navigating the Sea Change
    G. Steven Burrill, Burrill & Company

--  Industrialization of mAb Production - Implications, Challenges and
    Dana Anderson, Ph.D., Genentech, Inc.

--  Manufacturing Synagis: Life Cycle Management of a Life Saving Antibody
    Jeffrey Baker, Ph.D., MedImmune

--  Lessons Learned and Where are We Going? A CMO's Perspective
    John McGrath, Lonza Biologics

--  Global Regulatory Strategies for Validation and Transfer of Biotech
    Processes and Products
    Robert L. Garnick, Ph.D., Lone Mountain Biotechnology and Medical
    Devices, Inc.

--  The Critical Elements of a Successful Regulatory Filing for Outsourcing
    Biopharmaceutical Manufacturing
    Terry Milby, M.S., Genentech, Inc.

Plus, the event features 48 extensive case studies, including: Results from the CMC Biotech Working Group Case Study co-presented by Eli Lilly and Company and Pfizer Inc.

Attendees may choose to attend one conference or attend the full week with the all access pass. This event also includes two exhibit halls with over 60 supplier companies, open to attendees. Complete details on these events can be found at

Writers and editors are encouraged to attend. For a press pass please contact Dawn O'Connor at

IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. For more information, visit

Contact Information

  • Contact:
    Dawn O'Connor
    IBC Life Sciences
    (508) 614-1679
    Email Contact